What is budesonide used for in eosinophilic esophagitis?
Budesonide is a corticosteroid used to treat eosinophilic esophagitis (EoE) by reducing inflammation and eosinophil activity in the esophagus [1]. In EoE, a typical goal is to improve symptoms and reduce the number of eosinophils seen on esophageal biopsy [1].
How is budesonide taken for eosinophilic esophagitis?
For EoE, budesonide is commonly delivered as an oral “topical” steroid, meaning it is designed to coat the esophagus rather than work mainly through whole-body absorption [1]. Typical approaches include swallowed forms (often in a way that keeps the medication in the esophagus briefly) rather than inhaling it for lung use [1].
What benefits should patients expect?
Budesonide treatment can improve EoE-related symptoms and lower esophageal eosinophil counts in many patients [1]. Response varies by person, so clinicians generally pair symptom monitoring with follow-up endoscopy and biopsy when assessing whether inflammation is truly controlled [1].
Who might not be a good candidate?
Because budesonide is a corticosteroid, clinicians consider risks related to steroid exposure, including infections and other steroid-associated side effects, when deciding whether to use it for EoE [1]. The best choice can also depend on how severe the disease is and whether narrowing/strictures are present, which may require additional management beyond medication [1].
What side effects are commonly asked about?
Patients often ask about effects from “swallowed” steroids. Reported concerns with corticosteroids in EoE commonly include local effects such as oral or esophageal irritation and yeast infections, plus the general steroid-related risks that come with any corticosteroid exposure [1]. Clinicians may also advise mouth rinsing after dosing to reduce local side effects, depending on the specific budesonide formulation used.
How long is treatment usually continued?
EoE is typically a chronic condition, so many patients need ongoing or repeated therapy to maintain control after an initial response [1]. Treatment duration and tapering (or maintenance dosing) depend on symptom response, biopsy findings, and the overall disease course [1].
Is budesonide different from other EoE medicines?
Budesonide is one of several anti-inflammatory options used in EoE; choices also depend on patient preferences, access to therapy, and how the disease is responding [1]. A clinician will weigh factors like formulation convenience, prior response, and whether dietary therapy or other medications are being used alongside or instead of budesonide [1].
What happens if budesonide doesn’t work?
If symptoms persist and/or follow-up biopsy still shows active eosinophilic inflammation, clinicians may adjust the treatment plan, which can include changing the medication strategy or considering other EoE approaches [1]. Some patients also have complications like strictures where endoscopic evaluation and dilation may be needed in addition to anti-inflammatory treatment [1].
---
Sources
[1] https://www.ncbi.nlm.nih.gov/books/NBK560645/